Pregnant woman with transient diabetes insipidus resistant to 1-desamino-8-D-arginine vasopressin

被引:7
|
作者
Jin-No, Y
Kamiya, Y
Okada, M
Watanabe, O
Ogasawara, M
Fujinami, T
机构
[1] Nagoya City Univ, Sch Med, Dept Internal Med 3, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Nagoya City Univ, Sch Med, Dept Obstet & Gynecol, Nagoya, Aichi 4678601, Japan
关键词
diabetes insipidus; pregnancy; prostaglandin; hydronephrosis; magnetic resonance imaging;
D O I
10.1507/endocrj.45.693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We encountered a pregnant woman with transient diabetes insipidus which developed during the third trimester. A hypertonic saline infusion study did not concentrate the osmolality of urine. Her laboratory data showed hypokalemia, hyperreninemia, an increased concentration of plasma aldosterone and an increased urinary excretion rate of prostaglandin E-2, which resembled hyperprostaglandin E-syndrome. T1-weighted magnetic resonance imaging of the posterior pituitary gland revealed decreased intensity. Polyuria reached 4-6 L daily, and urine osmolality remained dilute despite a lapse of four days since treatment with intranasal 1-desamino-8-D-arginine vasopressin (dDAVP: 10-25 mu g every 12 h). The patient was conservatively managed without medical treatment, then delivered in the 38th week of pregnancy without complication. The osmolality of the patient's urine was higher than that of the plasma when tested 3 days postpartum. The abnormality of magnetic resonance imaging of the posterior pituitary gland disappeared at 6 months after delivery. We consider that subclinical nephrogenic diabetes insipidus in our patient was exacerbated during pregnancy.
引用
收藏
页码:693 / 696
页数:4
相关论文
共 50 条
  • [1] 1-DESAMINO-8-D-ARGININE VASOPRESSIN (DDAVP) IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS
    BRINK, HS
    DERKX, FHM
    BOOMSMA, F
    BROMMER, EJP
    SCHALEKAMP, MADH
    NETHERLANDS JOURNAL OF MEDICINE, 1993, 43 (1-2): : 5 - 12
  • [2] PHARMACOKINETICS OF 1-DESAMINO-8-D-ARGININE VASOPRESSIN (DDAVP) IN PATIENTS WITH CENTRAL DIABETES-INSIPIDUS
    PULLAN, PT
    BURGER, HG
    JOHNSTON, CI
    CLINICAL ENDOCRINOLOGY, 1978, 9 (03) : 273 - 278
  • [3] 1-DESAMINO-8-D-ARGININE VASOPRESSIN AND FIBRINOLYSIS IN MAN
    GADER, AMA
    COSTA, JD
    CASH, JD
    SCOTTISH MEDICAL JOURNAL, 1974, 19 (01) : 56 - 57
  • [4] DDAVP (1-DESAMINO-8-D-ARGININE VASOPRESSIN) CLEARANCE RATE
    STEGNER, H
    ARTMAN, HG
    LEAKE, RD
    FISHER, DA
    ACTA ENDOCRINOLOGICA, 1984, 107 (02): : 204 - 206
  • [5] 1-DESAMINO-8-D-ARGININE VASOPRESSIN (DDAVP) CONCENTRATION TEST
    RADO, JP
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1978, 275 (01): : 43 - 52
  • [6] TREATMENT OF DIABETES-INSIPIDUS WITH "1-DESAMINO-8-D-ARGININE-VASOPRESSIN
    IRMSCHER, K
    SENNEJUNKER, K
    WIEGELMANN, W
    SOLBACH, HG
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1974, 99 (48) : 2431 - 2437
  • [7] EFFECT OF 1-DESAMINO-8-D-ARGININE VASOPRESSIN (DDAVP) ON HUMAN PLATELETS
    YANG, X
    DISA, J
    RAO, AK
    THROMBOSIS RESEARCH, 1990, 59 (05) : 809 - 818
  • [8] Normal fibrinolytic responses to 1-desamino-8-D-arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin 2 gene
    vanLieburg, AF
    Knoers, VVAM
    Mallmann, R
    Proesmans, W
    vandenHeuvel, LPWJ
    Monnens, LAH
    NEPHRON, 1996, 72 (04): : 544 - 546
  • [9] DDAVP (1-DESAMINO-8-D-ARGININE VASOPRESSIN) - ANTAGONISM OF THE PRESSOR ACTIVITY OF ENDOGENOUS VASOPRESSIN
    DERKX, FHM
    TVELD, AJM
    SCHALEKAMP, MADH
    KIDNEY INTERNATIONAL, 1985, 27 (04) : 704 - 704
  • [10] Clinical case seminar - Hyatrogenic extrapontine myelinolysis in central diabetes insipidus: Are cyclosporine and 1-desamino-8-D-arginine vasopressin harmful in association?
    Maghnie, M
    Genovese, E
    Lundin, S
    Bonetti, F
    Arico, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06): : 1749 - 1751